By a GenomeWeb Staff Reporter
NEW YORK (GenomeWeb News) – Qiagen's acquisition strategy remains unchanged, and the firm is more likely to make smaller deals than any sort of big, transformative transaction, a company spokesperson told GenomeWeb Daily News today.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.
Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.
MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.
Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.